en · de · es · fr · pt
glossary-desk.peptides7501.com › Info › Sr9009 Background And Receptor Mechanism — Evidence Review

Sr9009 Background And Receptor Mechanism — Evidence Review

By Editorial Desk · published 2026-05-15 · last reviewed 2026-06-01 · Info

The short version of circadian rhythm fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2026-06-01 and is reviewed periodically as new material appears.

SR9009 Background and Receptor Mechanism

Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.

SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.

SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.

Background and Mechanism of SR9009

Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.

SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.

SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic REV-ERB agonistSmall-molecule nuclear receptor ligand
AppearanceOff-white to pale yellow solidTypical for research-grade powder
Solubility classSoluble in DMSO; low water solubilityCommon stock solutions use organic solvent
Typical stock solventDimethyl sulfoxideUsed for laboratory assays
Common analytical methodHPLC with UV or mass detectionUsed for identity and purity checks

Analytical Detection and Stability

Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.

Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.

Related pages on this site

Identity, Handling, and Regulation

Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.

Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.

Background and Receptor Pharmacology

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.

Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.

SR9009 Identity and Mechanism

REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.

SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.

SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.

Further detail

=== Relationships === Carrey dated singer Linda Ronstadt for eight months in 1983. On March 28, 1987, Carrey married former actress and Comedy Store waitress Melissa Womer. The couple had one daughter. Carrey and Womer divorced in 1995. On September 23, 1996, Carrey married his Dumb and Dumber co-star Lauren Holly; this second marriage lasted less than a year. From 1999 to 2000, Carrey was engaged to his Me, Myself & Irene co-star Renée Zellweger. In 2002, he was in a relationship with January Jones. In 2005, Carrey met model and actress Jenny McCarthy, and he made public in June 2006 that they were in a romantic relationship. They ended it in April 2010, with McCarthy noting in October 2010 that they had remained good friends. In early 2011, Carrey was seen holding hands with America's Next Top Model contestant Anchal Joseph, leading to speculation that the two were dating. In 2012, Carrey met Cathriona White, a makeup artist from County Tipperary, Ireland. They dated between 2012 and 2015. On September 28, 2015, White was found dead from a prescription drug overdose; the death was ruled a suicide by the Los Angeles County Medical Examiner. Carrey was a pallbearer at her funeral in Cappawhite, Ireland. In January 2019 when Carrey attended the Golden Globes 2019 Party, he was accompanied by his then-girlfriend Ginger Gonzaga. The couple split after less than a year of dating.

12 November – Downing Street confirms that Sue Gray will not take up a role as the prime minister's envoy to the nations and regions. The government sends a contingency of 470 delegates to the COP29 climate summit in Azerbaijan, with an estimated carbon dioxide footprint of at least 338 tons. The delegation is reported to comprise 354 government officials or ministers and 116 others including representatives from British overseas territories and crown dependencies, journalists, business figures and policy experts. By comparison, Italy sends 437, the US 405 and France 115. Starmer tells the COP29 climate conference that the UK will aim to reduce its emissions by 8% by 2035. Stephen Flynn, the SNP's leader at Westminster, announces his intention to stand at the 2026 Scottish Parliament election. Former Welsh government legal advisor Mick Antoniw and ex-minister Julie Morgan tell BBC News that subject to being passed at Westminster, the Terminally Ill Adults (End of Life) Bill would require a vote in the Senedd to become legal in Wales. 13 November – Health Secretary Wes Streeting orders a review into the potential cost to the NHS of implementing changes to the law regarding assisted dying. A report published by the Electoral Commission reveals that over half the 2024 general election candidates faced some kind of abuse. 14 November – Chancellor Rachel Reeves is reported to be planning the "biggest pension reform in decades" by merging council pension schemes into "pension megafunds" hoping they will boost economic growth.

Plutonium-238 has a half-life of 87.74 years. It emits a large amount of thermal energy with low levels of both gamma rays/photons and neutrons. Being an alpha emitter, it combines high energy radiation with low penetration and thereby requires minimal shielding. A sheet of paper can be used to shield against the alpha particles from 238Pu. One kilogram of the isotope generates about 570 watts of heat. These characteristics make it well-suited for electrical power generation for devices that must function without direct maintenance for timescales approximating a human lifetime. It is therefore used in radioisotope thermoelectric generators and radioisotope heater units such as those in the Cassini, Voyager, Galileo and New Horizons space probes, and the Curiosity and Perseverance (Mars 2020) Mars rovers. The twin Voyager spacecraft were launched in 1977, each containing a 500 watt plutonium power source. Over 30 years later, each source still produces about 300 watts which allows limited operation of each spacecraft. An earlier version of the same technology powered five Apollo Lunar Surface Experiment Packages, starting with Apollo 12 in 1969. 238Pu has also been used successfully to power artificial heart pacemakers, to reduce the risk of repeated surgery. It has been largely replaced by lithium-based primary cells, but as of 2003 there were somewhere between 50 and 100 plutonium-powered pacemakers still implanted and functioning in living patients in the United States. By the end of 2007, the number of plutonium-powered pacemakers was reported to be down to just nine.

The emerging discipline of geology also brought natural history and natural philosophy closer together; the establishment of the stratigraphic column linked the spatial distribution of organisms to their temporal distribution, a key precursor to concepts of evolution. Georges Cuvier and others made great strides in comparative anatomy and paleontology in the late 1790s and early 19th century. In a series of lectures and papers that made detailed comparisons between living mammals and fossil remains Cuvier was able to establish that the fossils were remains of species that had become extinct—rather than being remains of species still alive elsewhere in the world, as had been widely believed. Fossils discovered and described by Gideon Mantell, William Buckland, Mary Anning, and Richard Owen among others helped establish that there had been an 'age of reptiles' that had preceded even the prehistoric mammals. These discoveries captured the public imagination and focused attention on the history of life on earth. Most of these geologists held to catastrophism, but Charles Lyell's influential Principles of Geology (1830) popularised Hutton's uniformitarianism, a theory that explained the geological past and present on equal terms.

Sources: en.wikipedia.org

Background from the literature

Thus for a 2 m (6.6 ft) radius glass tube in lab conditions given above, the water would rise an unnoticeable 0.007 mm (0.00028 in). However, for a 2 cm (0.79 in) radius tube, the water would rise 0.7 mm (0.028 in), and for a 0.2 mm (0.0079 in) radius tube, the water would rise 70 mm (2.8 in).

15 episodes Rick Stein's Cornwall, Series 2, BBC Two, 2022. 15 episodes Rick Stein's Cornwall, Series 3, BBC Two, 2023. 10 episodes Rick Stein’s Food Stories, BBC Two, February 2024. 15 episodes Rick Stein’s Australia, BBC Two, January 2026. 6 episodes

==== Television and film ==== Ice-T was prominently featured as both a rapper and a breakdancer in Breakin' 'n' Enterin' (1983), a documentary about the early West Coast hip-hop scene. Ice-T's first film appearances were in the motion pictures, Breakin' (1984), and its sequel, Breakin' 2: Electric Boogaloo (1984). These films were released before Ice-T released his first LP, although he appears on the soundtrack to Breakin'. He has since stated he considers the films and his own performance in them to be "wack". In 1991, he embarked on a serious acting career, portraying police detective Scotty Appleton in Mario Van Peebles' action thriller New Jack City, gang leader Odessa (alongside Denzel Washington and John Lithgow) in Ricochet (1991), gang leader King James in Trespass (1992), followed by a notable lead role performance in Surviving the Game (1994), in addition to many supporting roles, such as J-Bone in Johnny Mnemonic (1995), and the marsupial mutant T-Saint in Tank Girl (1995). He was also interviewed in the Brent Owens documentary Pimps Up, Ho's Down, in which he claims to have had an extensive pimping background before getting into rap. He is quoted as saying "once you max something out, it ain't no fun no more. I couldn't really get no farther." He goes on to explain his pimping experience gave him the ability to get into new businesses. "I can't act, I really can't act, I ain't no rapper, it's all game. I'm just working these niggas." Later he raps at the Players Ball.

Malaysia's legal system is based on common law. Although the judiciary is theoretically independent, its independence has been called into question and the appointment of judges lacks accountability and transparency. The highest court in the judicial system is the Federal Court, followed by the Court of Appeal and two high courts, one for Peninsular Malaysia and one for East Malaysia. Malaysia also has a special court to hear cases brought by or against royalty. Race is a significant force in politics. Affirmative actions such as the New Economic Policy and the National Development Policy which superseded it, were implemented to advance the standing of the bumiputera, consisting of Malays and the indigenous tribes who are considered the original inhabitants of Malaysia, over non-bumiputera such as Malaysian Chinese and Malaysian Indians. These policies provide preferential treatment to bumiputera in employment, education, scholarships, business, and access to cheaper housing and assisted savings. However, it has generated greater interethnic resentment. There is ongoing debate over whether the laws and society of Malaysia should reflect Islamism or secularism. Islamic criminal laws passed by the Pan-Malaysian Islamic Party with the support of UMNO state assemblymen in the state legislative assembly of Kelantan have been unenforced by the federal government on the basis that criminal laws are the responsibility of the federal government.

In red onions, higher concentrations of quercetin occur in the outermost rings and in the part closest to the root, the latter being the part of the plant with the highest concentration. One study found that organically grown tomatoes had 79% more quercetin than non-organically grown fruit. Quercetin is present in various kinds of honey from different plant sources.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.

How does SR9009 work?

It binds REV-ERB alpha and REV-ERB beta and changes the expression of genes tied to metabolism and circadian rhythm. These changes can affect mitochondria and energy use in animal models. The exact chain from receptor binding to physiological outcome is still being mapped.

Is SR9009 a proven performance enhancer?

No reliable human trials show that SR9009 improves athletic performance. Some rodent studies report endurance changes, but these results are not proof of human benefit. Its use in sport is prohibited, and quality and safety data are lacking.

What is SR9009?

SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.

Network